Peripheral intravenous catheter non-infectious complications in adults: A systematic review and meta-analysis.
Marsh N, Webster J, Ullman AJ, Mihala G, Cooke M, Chopra V, Rickard CM.
J Adv Nurs. 2020 Dec;76(12):3346-3362. doi: 10.1111/jan.14565. Epub 2020 Oct 5.
Clinical Pharmacokinetics of Fosfomycin after Continuous Infusion Compared with Intermittent Infusion: a Randomized Crossover Study in Healthy Volunteers.
Al Jalali V, Matzneller P, Wulkersdorfer B, Chou S, Bahmany S, Koch BCP, Zeitlinger M.
Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01375-20. doi: 10.1128/AAC.01375-20. Print 2020 Dec 16.
Intravascular thrombophlebitis related to the peripheral infusion of amiodarone and vancomycin.
Mowry JL, Hartman LS.
West J Nurs Res. 2011 Apr;33(3):457-71. doi: 10.1177/0193945910380212. Epub 2010 Oct 14.
THROMBOPHLEBITIS after infusions.
[No authors listed]
Lancet. 1955 Sep 10;269(6889):541.
Infusion thrombophlebitis: the histological and clinical features.
Woodhouse CR.
Ann R Coll Surg Engl. 1980 Sep;62(5):364-8.
Risk of thrombophlebitis associated with continuous peripheral infusion of vancomycin: The effect of dilution.
Scarano M, D'Arrigo S, De Letteriis S, Grasso S, Pittiruti M, Scoppettuolo G.
J Vasc Access. 2024 Jan;25(1):107-112. doi: 10.1177/11297298221095778. Epub 2022 May 24.
Thrombophlebitis after intravenous infusion. Factors affecting its incidence.
Swanson JT, Aldrete JA.
Rocky Mt Med J. 1969 Apr;66(4):48-51.
[Sepsis after pharyngitis].
Schmid I, Licht A, Eich G.
Praxis (Bern 1994). 2008 Jan 9;97(1):30-2. doi: 10.1024/1661-8157.97.1.30.
Physical and chemical considerations on local thrombophlebitis during and after intravenous infusions or injections.
Lepoivre JA, Alderweireldt F, Delaruelle J.
Acta Anaesthesiol Belg. 1973;24(3):230-40.
[Incidence of infusion thrombophlebitis after infusion of glucose and fructose].
Thayssen P.
Ugeskr Laeger. 1973 Jan 8;135(2):74-6.
